Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Current Leases (2020 - 2025)

Historic Current Leases for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $1.5 million.

  • Pulse Biosciences' Current Leases rose 2732.61% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 2732.61%. This contributed to the annual value of $1.4 million for FY2024, which is 2807.18% up from last year.
  • As of Q3 2025, Pulse Biosciences' Current Leases stood at $1.5 million, which was up 2732.61% from $1.5 million recorded in Q2 2025.
  • Pulse Biosciences' Current Leases' 5-year high stood at $1.5 million during Q3 2025, with a 5-year trough of $629000.0 in Q1 2021.
  • Moreover, its 5-year median value for Current Leases was $1.0 million (2023), whereas its average is $1.0 million.
  • In the last 5 years, Pulse Biosciences' Current Leases skyrocketed by 54183.67% in 2021 and then tumbled by 1531.19% in 2022.
  • Pulse Biosciences' Current Leases (Quarter) stood at $1.1 million in 2021, then dropped by 15.31% to $896000.0 in 2022, then rose by 18.08% to $1.1 million in 2023, then increased by 28.07% to $1.4 million in 2024, then increased by 12.1% to $1.5 million in 2025.
  • Its Current Leases stands at $1.5 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.4 million for Q1 2025.